Breast Cancer Trial, Recruiting NCT07238894 Sponsor: Peking University People's Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07238894
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have had breast cancer confirmed through a core needle biopsy
  • People whose tumor can be clearly seen on an ultrasound scan
  • People who do not have conditions that would make cryoablation (a freezing treatment) unsafe, such as blood clotting disorders
  • People for whom standard surgery is not suitable — for example, because their overall health means they cannot safely have general anaesthetic, because their cancer has spread and cannot be removed by surgery, or because they have chosen not to have surgery
  • People who agree to have the ablation procedure and are willing to sign a consent form

Who may not be able to join:

  • People whose medical records are incomplete, including missing scan results or biopsy/pathology reports
  • People who are pregnant or currently breastfeeding
  • People who are known to have allergies, intolerances, or medical reasons that make cryotherapy (freezing treatment) unsafe — for example, a condition called cryoglobulinemia, or having an implanted electronic device such as a pacemaker
  • People considered to be in a vulnerable group, including those with neurological conditions, cognitive impairments, or who are critically ill (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 010-88324010

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peking University People's Hospital
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 June 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Ipsilateral breast cancer recurrence; the rate of comlications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov